Aubrey Rankin
2021
In 2021, Aubrey Rankin earned a total compensation of $3M as Former President, Innovation & Technology at Revance Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $159,086 |
|---|---|
| Option Awards | $669,632 |
| Salary | $395,000 |
| Stock Awards | $1,432,424 |
| Other | $327,149 |
| Total | $2,983,291 |
Rankin received $1.4M in stock awards, accounting for 48% of the total pay in 2021.
Rankin also received $159.1K in non-equity incentive plan, $669.6K in option awards, $395K in salary and $327.1K in other compensation.
Rankings
In 2021, Aubrey Rankin's compensation ranked 4,457th out of 12,405 executives tracked by ExecPay. In other words, Rankin earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,457 out of 12,405 | 64th |
Division Manufacturing | 1,832 out of 5,494 | 67th |
Major group Chemicals And Allied Products | 761 out of 2,369 | 68th |
Industry group Drugs | 678 out of 2,090 | 68th |
Industry Pharmaceutical Preparations | 483 out of 1,537 | 69th |
Pay ratio
| Aubrey Rankin's Pay | $2,983,291 |
|---|---|
| Median Employee's Pay | $248,326 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Aubrey Rankin was $2,983,291.
The annual total compensation of the median employee at Revance Therapeutics was $248,326.
The ratio of Aubrey Rankin's pay to the pay of median employee was therefore 12 to one.
Source: SEC filing on March 24, 2022.
Rankin's colleagues
We found four more compensation records of executives who worked with Aubrey Rankin at Revance Therapeutics in 2021.